{
  "id": 19194476,
  "title": "FDA is requiring weight loss drug makers to add a vision loss warning",
  "url": "https://urgent.news/2026/11/09/fda-is-requiring-weight-loss-drug-makers-to-add-a-vision-loss-warning",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-09T18:50:30.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/fda-weight-loss-drugs-vision-loss-warning-110926"
  },
  "original_language": "en",
  "account": null,
  "summary": "The warning covers all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a rare eye condition called NAION",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}